Dignitana AB Publishes Interim Report for Q2 2018
Solid progress and growth
Dignitana AB today posted the company’s Interim Report for the period ending 30 June 2018. Dignitana has shown a 51 percent increase in sales over the first quarter 2018.
"The results we posted this quarter represent a very important milestone for Dignitana. Quarterly revenue for the company reached 9,022 TSEK. With the organizational restructuring we have implemented, the company is close to reaching a breakeven point in regard to our costs for continuing operations." - William Cronin, CEO, Dignitana AB
To download the full report click here.
This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation and/or the Swedish Securities Market Act. The information was submitted for publication, by the above contact, for publication at 8:00 (CET), 21 August 2018.
This press release has been prepared in both Swedish and English versions. In the event of discrepancies between the two versions, the English version shall govern.
William Cronin, CEO, Dignitana AB firstname.lastname@example.org +1 469 917 5555
Mikael Wahlgren, Vice VD, Dignitana AB email@example.com +46 709 33 72 20
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.